9Bio Therapeutics
PrivateLast Round
Accelerator
Jun 23, 2025
Total Funding Raised
$429,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
9Bio Therapeutics is a biotechnology company that develops oncology therapeutics using its AI-guided structural biology platform to design drugs that selectively target tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
9Bio Therapeutics Comparables
Compare 9Bio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 82% | |
| BioAtla | 73% | |
| Tentarix | 71% | |
9Bio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 23, 2025 | ||||
| Grant | Mar 20, 2025 | ||||
| Accelerator | May 21, 2024 |
9Bio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| adMare BioInnovations | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 3033% MoM, reaching 2.2K.
- Jan 2, 2026
Monthly visitors increased 154% MoM.
9Bio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 9Bio Therapeutics's valuation, stock price, and market status.